Self-Monitoring Blood Glucose Devices Market to Reach $11.9 Billion at 4.2% CAGR by 2027
November 04, 2020 10:00 ET
|
Allied Market Research
Portland, OR, Nov. 04, 2020 (GLOBE NEWSWIRE) -- According to a new report published by Allied Market Research, titled, "Self-monitoring Blood Glucose Devices Market by Product, Application, and End...
Worldwide Continuous Glucose Monitoring Device Industry to 2026 - Key Drivers and Restraints of the Market
August 31, 2020 05:04 ET
|
Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "Global Continuous Glucose Monitoring Device Market By Component, By End User, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been...
Continuous Glucose Monitoring Devices Market To Reach USD 1.25 Billion By 2026 | Reports And Data
November 11, 2019 21:30 ET
|
Reports and Data
New York, Nov. 11, 2019 (GLOBE NEWSWIRE) -- High incidence of diabetes, increasing geriatric population & continuous technological advancements across the globe are the key factors contributing...
UPDATE - Global Artificial Intelligence in Diabetes Management Market is Expected to Grow at a CAGR of 37.7% in 2019-2027: Absolute Markets Insights
March 07, 2019 07:01 ET
|
Absolute Markets Insights
PUNE, India, March 07, 2019 (GLOBE NEWSWIRE) -- Type 2 diabetes is a chronic condition in which an individual is unable to produce or use insulin well, that subsequently results in elevated blood...
Global Artificial Intelligence in Diabetes Management Market is Expected to Grow at a CAGR of 37.7% in 2019-2027: Absolute Markets Insights
March 06, 2019 07:29 ET
|
Absolute Markets Insights
PUNE, India, March 06, 2019 (GLOBE NEWSWIRE) -- Type 2 diabetes is a chronic condition in which an individual is unable to produce or use insulin well, that subsequently results in elevated blood...
InSpark Technologies Announces the Results of the Home Use and Human Factors Study of Vigilant(TM) in People with Diabetes
June 11, 2016 11:00 ET
|
InSpark Technologies
Vigilant met or exceeded all human factors criteria for safety, comprehension and ease of useEarly evidence of clinical benefit was demonstrated by a 51 percent reduction in the proportion of blood...
Cellnovo Wins BIOVISION Investor Conference Award
June 11, 2014 09:10 ET
|
Cellnovo
SWANSEA, UK, June 11, 2014 (GLOBE NEWSWIRE) -- Cellnovo, the leading innovator in mobile diabetes management, announced today that the Company has received the BIOVISION Investment Conference 2014...
Asante Partners With Diasend to Streamline Snap Insulin Pump Data Management
June 12, 2013 10:27 ET
|
Asante Solutions, Inc.
SUNNYVALE, Calif., June 12, 2013 (GLOBE NEWSWIRE) -- Asante Solutions Inc., manufacturer of the new Asante SnapTM Insulin Pump, has partnered with Diasend, developer of a system to transmit, store and...
PositiveID Corporation Provides Mid-Year Update to Stockholders
August 23, 2012 08:30 ET
|
PositiveID Corporation
Company Makes Significant Progress Realigning Its Business to Focus on Molecular Diagnostics
Company Continues Internal Testing of Its M-BAND System and Discussions With Strategic Partners in...
PositiveID Corporation and Simplex Healthcare Partner to Provide iglucose System to People With Diabetes
July 10, 2012 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., July 10, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes...